MSI-H/ MMRd
Quiénes somos
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer
A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors
An Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and Metastasis
GCC19CART for Patients With Metastatic Colorectal Cancer
Sotorasib y panitumumab frente a la elección del investigador para participantes con sarcoma de rata de Kirsten (KRAS) con mutación p.G12C (CodeBreak 300)
Un estudio de CPI-0209 en pacientes con tumores sólidos y linfomas avanzados
Evaluación de la inmunogenicidad de pING-hHER3FL
Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.
Investigación clínica de células CAR-NK específicas de ROBO1 en pacientes con tumores sólidos
